Gilead creates generic HIV drug plan and advocates for urgent expansion

By Dan McKay (October 3, 2024, 9:28 p.m. EDT) — Gilead Sciences Inc. announced a plan this week to allow six drugmakers to produce generic lenacapavir to help combat the HIV pandemic in 120 low-income countries Contributing was praised as a welcome move on Thursday, even as advocacy groups urged the company to expand the effort…

Law360 is there, so you are too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments, so you can act quickly and confidently. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features like

• Daily newsletters
• Expert analysis
• Mobile app
• Advanced search
• Information about the judge
• Real-time alerts
• Over 450,000 searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.